DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF FLEXIBLE DOSE DIVALPROEX SODIUM
灵活剂量双丙戊酸钠的双盲、安慰剂对照试验
基本信息
- 批准号:7607864
- 负责人:
- 金额:$ 0.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-23 至 2007-11-30
- 项目状态:已结题
- 来源:
- 关键词:Aggressive behaviorAgitationAngerAttention deficit hyperactivity disorderBehaviorChildComputer Retrieval of Information on Scientific Projects DatabaseDoseFundingGrantInstitutionPharmaceutical PreparationsProblem behaviorPurposeResearchResearch PersonnelResourcesSelf-control as a personality traitSemisodium ValproateSourceSymptomsUnited States National Institutes of Healthdouble-blind placebo controlled trialinattention
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The purpose of this study is to investigate a medication treatment strategy for children who have both ADHD and other difficulties with behavior and self control particularly aggression. Medication for ADHD can help both the main symptoms of ADHD ( inattention,restlessness,inpulsiveness) and conduct problem behaviors (trouble following directions and rules, aggressiveness, anger control difficulties,etc.).
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
这项研究的目的是探索一种药物治疗策略,用于同时患有ADHD和其他行为和自我控制困难的儿童,特别是攻击性儿童。治疗ADHD的药物既可以帮助ADHD的主要症状(注意力不集中、躁动、好动),也可以进行问题行为(难以遵循指示和规则、攻击性、愤怒控制困难等)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph C Blader其他文献
Joseph C Blader的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph C Blader', 18)}}的其他基金
CLINICAL TRIAL: ADJUNCTIVE TREATMENT WITH DIVALPROEX OR RISPERIDONE IN CHILDREN
临床试验:双丙戊酸钠或利培酮对儿童的辅助治疗
- 批准号:
8167261 - 财政年份:2010
- 资助金额:
$ 0.93万 - 项目类别:
CLINICAL TRIAL: ADJUNCTIVE TREATMENT WITH DIVALPROEX OR RISPERIDONE FOR AGGRESSI
临床试验:用双丙戊酸钠或利培酮辅助治疗攻击行为
- 批准号:
7951956 - 财政年份:2009
- 资助金额:
$ 0.93万 - 项目类别:
Stepped Pharmacotherapy for Aggressive Youth with ADHD
患有多动症的攻击性青少年的阶梯式药物治疗
- 批准号:
8067159 - 财政年份:2008
- 资助金额:
$ 0.93万 - 项目类别:
Stepped Pharmacotherapy for Aggressive Youth with ADHD
患有多动症的攻击性青少年的阶梯式药物治疗
- 批准号:
7845036 - 财政年份:2008
- 资助金额:
$ 0.93万 - 项目类别:
Stepped Pharmacotherapy for Aggressive Youth with ADHD
患有多动症的攻击性青少年的阶梯式药物治疗
- 批准号:
7659477 - 财政年份:2008
- 资助金额:
$ 0.93万 - 项目类别:
Stepped Pharmacotherapy for Aggressive Youth with ADHD
患有多动症的攻击性青少年的阶梯式药物治疗
- 批准号:
8247829 - 财政年份:2008
- 资助金额:
$ 0.93万 - 项目类别:
Stepped Pharmacotherapy for Aggressive Youth with ADHD
患有多动症的攻击性青少年的阶梯式药物治疗
- 批准号:
8476726 - 财政年份:2008
- 资助金额:
$ 0.93万 - 项目类别:
DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF FLEXIBLE DOSE DIVALPROEX SODIUM
灵活剂量双丙戊酸钠的双盲、安慰剂对照试验
- 批准号:
7375359 - 财政年份:2005
- 资助金额:
$ 0.93万 - 项目类别:
DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF FLEXIBLE DOSE DIVALPROEX SODIUM
灵活剂量双丙戊酸钠的双盲、安慰剂对照试验
- 批准号:
7203644 - 财政年份:2004
- 资助金额:
$ 0.93万 - 项目类别:
Stepped Pharmacotherapy for Aggressive Youth with ADHD
患有多动症的攻击性青少年的阶梯式药物治疗
- 批准号:
6851430 - 财政年份:2002
- 资助金额:
$ 0.93万 - 项目类别:
相似海外基金
Relationship between Biomarkers of Oxidative Stress and Agitation Severity in Moderate-to-severe Alzheimer's Disease
中重度阿尔茨海默病氧化应激生物标志物与躁动严重程度之间的关系
- 批准号:
497994 - 财政年份:2023
- 资助金额:
$ 0.93万 - 项目类别:
Effects of dexmedetomidine on agitation in critically ill TBI patients - DEX-TBI
右美托咪定对危重 TBI 患者躁动的影响 - DEX-TBI
- 批准号:
488402 - 财政年份:2023
- 资助金额:
$ 0.93万 - 项目类别:
Operating Grants
Co-design and evaluation of sensor-instrumented ‘smart socks’ (MPATIX) to improve management of distress and agitation for people with dementia
共同设计和评估传感器仪表“智能袜子”(MPATIX),以改善痴呆症患者的痛苦和躁动管理
- 批准号:
10055596 - 财政年份:2023
- 资助金额:
$ 0.93万 - 项目类别:
Collaborative R&D
Identifying pre-agitation biometric signature in dementia patients: A feasibility study
识别痴呆症患者的躁动前生物识别特征:可行性研究
- 批准号:
486612 - 财政年份:2022
- 资助金额:
$ 0.93万 - 项目类别:
Studentship Programs
Relationship between 4-Hydroxynonenal and Agitation Severity in Alzheimer’s Disease
4-羟基壬烯醛与阿尔茨海默病患者躁动严重程度之间的关系
- 批准号:
486589 - 财政年份:2022
- 资助金额:
$ 0.93万 - 项目类别:
Studentship Programs
Agitation in Alzheimer's Disease: Identification and Prediction Using Digital Behavioral Markers and Indoor Environmental Factors
阿尔茨海默病中的躁动:使用数字行为标记和室内环境因素进行识别和预测
- 批准号:
10404523 - 财政年份:2021
- 资助金额:
$ 0.93万 - 项目类别:
Clinical Decision Support Tool to Assess Risk and Prevent Agitation Events
用于评估风险和预防躁动事件的临床决策支持工具
- 批准号:
10683499 - 财政年份:2021
- 资助金额:
$ 0.93万 - 项目类别:
Development of Memesto, a wearable repetitive message and music therapy device that senses and reduces agitation in persons with AD/ADRD.
开发 Memesto,一种可穿戴式重复信息和音乐治疗设备,可感知并减少 AD/ADRD 患者的躁动。
- 批准号:
10322846 - 财政年份:2021
- 资助金额:
$ 0.93万 - 项目类别:
Agitation in Alzheimer's Disease: Identification and Prediction Using Digital Behavioral Markers and Indoor Environmental Factors
阿尔茨海默病中的躁动:使用数字行为标记和室内环境因素进行识别和预测
- 批准号:
10190522 - 财政年份:2021
- 资助金额:
$ 0.93万 - 项目类别:
Clinical Decision Support Tool to Assess Risk and Prevent Agitation Events
用于评估风险和预防躁动事件的临床决策支持工具
- 批准号:
10365272 - 财政年份:2021
- 资助金额:
$ 0.93万 - 项目类别:














{{item.name}}会员




